PFE Pfizer, Inc.
$29.80▲ +0.03%
Healthcare
Other
After hours
$29.78▼ -0.07%
Oct 27, 5:44 PM ET
Volume 23.36M
Avg Volume (10D) 28.90M
Key Metrics & Fundamentals
Market Cap
$169.85B
P/E Ratio
39.2
Div Yield
5.77%
52W Range
23.62 - 30.44
% vs 50 MA
4.88%
% vs 200 MA
11.49%
RSI-14
61.9
MACD Histogram
+0.0800
Beta (1Y vs SPY)
0.24
Free Cash Flow
$302.00M
Gross Rev
$15.03B
Gross Profit
$10.94B
EBITDA
$5.60B
COGS
$4.09B
Operating Exp
$7.41B
Operating Income
$3.54B
EBIT
$3.54B
Pretax Income
-$653.00M
Net Income
-$248.00M
EPS (Diluted)
-0.04
Price & Volume History
Loading chart…
Recent News
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now
Motley Fool · Oct 27, 2026 3:09 PM ET
Pfizer (PFE) Scores Phase 3 Cancer Win As FDA Broadens Another Oncology Approval
Simply Wall St. · Oct 27, 2026 1:12 PM ET
Has Regeneron Stock Become A Different Bet?
Trefis · Oct 27, 2026 12:44 PM ET
$200,000 in Dividend Stocks: How Much More Could You Keep in a Roth IRA?
24/7 Wall St. · Oct 27, 2026 11:47 AM ET
3 Dirt Cheap Dividend Stocks to Buy Hand Over Fist
Motley Fool · Oct 27, 2026 10:35 AM ET
Buy, Hold or Sell ABBV Stock? Key Tips Ahead of Q3 Earnings
Zacks · Oct 27, 2026 10:32 AM ET
Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
Zacks · Oct 27, 2026 10:15 AM ET
Medicus Pharma CEO to present precision oncology progress at global biotech conferences
Proactive · Oct 27, 2026 9:26 AM ET
NYC’s Office-Conversion Projects Are Back After a Big Summer Scare
The Wall Street Journal · Oct 27, 2026 9:19 AM ET
Pfizer's Phase 3 Study of Elrexfio to Treat Relapsed or Refractory Multiple Myeloma Meets Primary Endpoint
MT Newswires · Oct 27, 2026 9:12 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PFE's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.